Patient demographics and baseline characteristics
| . | Total, N = 10 . |
|---|---|
| Age, y | |
| Median (range) | 72.0 (68.0-85.0) |
| Sex, n (%) | |
| Male | 5 (50.0) |
| Female | 5 (50.0) |
| Race, n (%) | |
| White | 9 (90.0) |
| Other | 1 (10.0) |
| Ethnicity, n (%) | |
| Hispanic or Latino | 0 |
| Not Hispanic or Latino | 10 (100.0) |
| Body mass index (kg/m2) | |
| Median (range) | 28.42 (20.7-38.6) |
| Previous exposure to chemotherapy for an indication other than AML, n (%) | 3 (30.0) |
| Previous exposure to radiation therapy, n (%) | 4 (40.0) |
| . | Total, N = 10 . |
|---|---|
| Age, y | |
| Median (range) | 72.0 (68.0-85.0) |
| Sex, n (%) | |
| Male | 5 (50.0) |
| Female | 5 (50.0) |
| Race, n (%) | |
| White | 9 (90.0) |
| Other | 1 (10.0) |
| Ethnicity, n (%) | |
| Hispanic or Latino | 0 |
| Not Hispanic or Latino | 10 (100.0) |
| Body mass index (kg/m2) | |
| Median (range) | 28.42 (20.7-38.6) |
| Previous exposure to chemotherapy for an indication other than AML, n (%) | 3 (30.0) |
| Previous exposure to radiation therapy, n (%) | 4 (40.0) |
n, number of patients in subset.